ADX
Addex Therapeutics ADR
Stock
Stock
ISIN: US00654J2069
Ticker: ADXN
US00654J2069
ADXN
Price
Price
CHART BY
Frequently asked questions
What is Addex Therapeutics ADR's market capitalization?
The market capitalization of Addex Therapeutics ADR is $9.24M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Addex Therapeutics ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Addex Therapeutics ADR is 0.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Addex Therapeutics ADR?
Addex Therapeutics ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $14.46. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Addex Therapeutics ADR's stock?
Currently, 2 analysts cover Addex Therapeutics ADR's stock, with a consensus target price of $28.64. Analyst ratings provide insights into the stock's expected performance.
What is Addex Therapeutics ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Addex Therapeutics ADR reported a revenue of $345.03K.
What is the EBITDA for Addex Therapeutics ADR?
Addex Therapeutics ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$3.35M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Addex Therapeutics ADR?
Addex Therapeutics ADR has a free cash flow of -$5.39M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Addex Therapeutics ADR have, and what sector and industry does it belong to?
Addex Therapeutics ADR employs approximately 2 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Addex Therapeutics ADR's shares?
The free float of Addex Therapeutics ADR is 819.31K. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $9.24M
- EPS (TTM)
- $14.46
- Free Float
- 819.31K
- P/E ratio (TTM)
- 0.78
- Revenue (TTM)
- $345.03K
- EBITDA (TTM)
- -$3.35M
- Free Cashflow (TTM)
- -$5.39M
Pricing
- 1D span
- $7.96$9.44
- 52W span
- $6.80$13.23
Analyst Ratings
The price target is $28.64 and the stock is covered by 2 analysts.
Buy
0
Hold
0
Sell
2
Information
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
- Employees
- 2
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US00654J2069
- Primary Ticker
- ADXN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet